Table 4.
Variables | Patient category | BMI | Mean ± SD | Model A | Model B | Model C | |||
---|---|---|---|---|---|---|---|---|---|
Fold change | Adjusted difference (95% CI) | Fold change | Adjusted difference (95% CI) | Fold change | Adjusted difference (95% CI) | ||||
HOMA-IR | Healthy | Normal | 1.29 ± 0.15 | 1.0 | Ref | ||||
High | 2.20 ± 0.19 | 1.71 | 0.68 (0.01, 1.35)* | 1.0 | Ref | ||||
PCOS | Normal | 1.23 ± 0.24 | 0.95 | 0.05 (− 0.74, 0.84) | 0.56 | − 0.63 (− 1.53, 0.27) | 1.0 | Ref | |
High | 3.53 ± 0.22 | 2.74 | 1.48 (0.71. 2.25)*** | 1.60 | 0.80 (− 0.03, 1.64) | 2.87 | 1.43 (0.48, 2.38)*** | ||
Cholesterol (mmol/L) | Healthy | Normal | 4.63 ± 0.07 | 1.0 | Ref | ||||
High | 5.10 ± 0.08 | 1.10 | 0.42 (0.09, 0.74)** | 1.0 | Ref | ||||
PCOS | Normal | 4.71 ± 0.11 | 1.02 | 0.09 (− 0.30, 0.48) | 0.92 | − 0.33 (− 0.77, 0.11) | 1.0 | Ref | |
High | 4.96 ± 0.10 | 1.07 | 0.16 (− 0.21, 0.54) | 0.97 | − 0.25 (− 0.66, 0.16) | 1.05 | 0.08 (− 0.39, 0.54) | ||
Triglycerides (mmol/L) | Healthy | Normal | 0.80 ± 0.06 | 1.0 | Ref | ||||
High | 1.30 ± 0.07 | 1.63 | 0.35 (0.15, 0.55)*** | 1.0 | Ref | ||||
PCOS | Normal | 0.81 ± 0.09 | 1.01 | 0.03 (− 0.21, 0.27) | 0.62 | − 0.32 (− 0.59, − 0.05)* | 1.0 | Ref | |
High | 1.24 ± 0.08 | 1.55 | 0.36 (0.13, 0.59)*** | 0.95 | 0.01 (− 0.24, 0.26) | 1.53 | 0.33 (0.04, 0.61)* | ||
HDL (mmol/L) | Healthy | Normal | 1.59 ± 0.03 | 1.0 | Ref | ||||
High | 1.35 ± 0.03 | 0.85 | − 0.21 (− 0.36, − 0.07)*** | 1.0 | Ref | ||||
PCOS | Normal | 1.63 ± 0.04 | 1.03 | 0.00 (− 0.17, 0.17) | 1.21 | 0.21 (0.01, 0.40)* | 1.0 | Ref | |
High | 1.28 ± 0.04 | 0.81 | − 0.33 (− 0.50, − 0.17)*** | 0.95 | − 0.12 (− 0.30, 0.06) | 0.74 | − 0.33 (− 0.53, − 0.12)*** | ||
LDL (mmol/L) | Healthy | Normal | 2.66 ± 0.06 | 1.0 | Ref | ||||
High | 3.20 ± 0.08 | 1.20 | 0.45 (0.17, 0.74)*** | 1.0 | Ref | ||||
PCOS | Normal | 2.72 ± 0.10 | 1.02 | 0.15 (− 0.19, 0.49) | 0.85 | − 0.30 (− 0.69, 0.08) | 1.0 | Ref | |
High | 3.12 ± 0.09 | 1.18 | 0.37 (0.04, 0.70)* | 0.98 | − 0.08 (− 0.44, 0.27) | 1.15 | 0.22 (− 0.19, 0.62) |
HOMA‐IR, homoeostatic model assessment‐insulin resistance; HDL, high-density lipoprotein; LDL, low-density lipoprotein